SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

028300 (028300) News

Track canonical SquawkNews coverage tagged to 028300, 028300. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol 028300 Asset market Sector Markets 90 days 1 Updated Sep 22, 2026, 01:46 PM UTC Open live news feed
M FDA grants conditional acceptance of LYRFIGTU brand name Elevar Therapeutics says the FDA granted conditional acceptance of LYRFIGTU as the brand name for lirafugratinib, which is under FDA Priority Review. REGULATION | Sep 22, 2026, 01:46 PM UTC